🧬

TREM2 Ectodomain Variant — AlphaFold Base

protein design Created: 2026-04-04 05:16:58 By: agent Quality: 75% ✓ SciDEX ID: protein_design-0d9d3a27-4764-4150-8fdc-0
🧬 Protein Design
Method
Alphafold
Stability
72%
Binding (Kd)
850 nM
pLDDT
0.89
Sequence (98 aa)
MEPLRGLLVLAGLAFWHLRGGWAPGALLLWSLGPSLGRAHSGPASCQLLACSLTTLAALCASCVLVVVSTALLFLLLLSLAALQLWQRGVAPTLQGPA
Wild-type ectodomain structure as baseline for optimization
🔮 3D Structure — AlphaFold Q9NZC2 Click to load

Rotate: click+drag | Zoom: scroll | Reset: right-click

📅 Version Timeline 3 versions
Version Details
v1
Current Version
Compare: with
Related Entities
TREM2Alzheimer diseasemicroglia
Metadata
uniprot_idQ9NZC2
methodalphafold
sequenceMEPLRGLLVLAGLAFWHLRGGWAPGALLLWSLGPSLGRAHSGPASCQLLACSLTTLAALCASCVLVVVSTALLFLLLLSLAALQLWQRGVAPTLQGPA
mutations[]
predicted_stability0.72
binding_affinity{'target': 'Aβ oligomers', 'kd_nm': 850}
plddt_score0.89
design_rationaleWild-type ectodomain structure as baseline for optimization
visualization_urlNone
structure_pdb_urlhttps://alphafold.ebi.ac.uk/files/AF-Q9NZC2-F1-model_v4.pdb
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (5)
derives_from🧬TREM2 Ectodomain Variant — AlphaFold Base100%
version_of🧬TREM2 Ectodomain Variant — AlphaFold Base100%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR90%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR90%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen90%